ACD Diagnostic Pipeline
ACD is developing a portfolio of novel cancer diagnostic tests powered by RNAscope. These tests could lead to clinical breakthroughs in personalized management of various oncological diseases, including:
- Head and Neck Cancer
- Cervical Cancer
- B-Cell Lymphoma
- Melanoma
- Breast Cancer
- Circulating Tumor Cells (CTC)

Please contact partnership@acdbio.com if interested in any of our clinical studies.

